ANGELA UNFRIED: Open Payments
NPI 1922005289 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 23 payments from 12 companies in 2025. Trend: 2023 $767 · 2024 $768 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $75 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Novo Nordisk Inc | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| HEARTFLOW, INC. | 1 | $29 |
| BridgeBio Pharma, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: LifeVest, AMVUTTRA, LEQVIO, Wegovy, EVKEEZA, Kerendia, VERQUVO, FFRct.
Industry payments across IN — which companies pay providers there.
